此次进博会上，哈尔滨血液病肿瘤研究所所长马军教授表示，多发性骨髓瘤作为一种高度异质性的血液肿瘤，几乎所有患者在治疗过程中都会面临复发或耐药。随着疾病的进展，患者复发次数越多，后续治疗难度越高，复发后的缓解深度也随之降低，持续缓解时间不断缩短。因此，既 ...

肺是持续暴露于外界刺激的器官，肺部的免疫监测功能对于快速有效地响应病原体刺激以激活宿主免疫应答至关重要。肺部免疫功能对抵抗各种肺部疾病引起的肺部损伤至关重要，包括肺炎、肺癌、哮喘和慢性阻塞性肺病等，因此，研究人员迫切需要阐明肺部免疫功能的细胞和分子基 ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

12月12日，CDE官网显示，赛诺菲旗下CD38单抗艾沙妥昔单抗注射液（isatuximab）的上市申请已获受理，用于治疗多发性骨髓瘤。 Isatuximab是一种单克隆 ...

APG-2575（Lisaftoclax）是亚盛医药自主研发的、具全球best-in-class潜力的新型口服Bcl-2选择性抑制剂，在多种血液肿瘤和实体瘤治疗领域具备广阔的治疗潜力。亚盛医药将在此次ASH年会上，口头报告该品种治疗复发/难治（R/R）多发性骨髓瘤 ...

Mougiakakos D. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases.

A new study reveals a modular CAR-T approach that effectively targets heterogeneous antigens in paediatric acute myeloid leukaemia, enhancing treatment success through combinatorial targeting.

Imvotamab (CD20 x CD3) trials in rheumatoid arthritis, systemic lupus erythematosus and myositis ongoing; initial clinical data expected by ...

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...